$VLN
Valens Semiconductor Ltd. Stock $vln

$vln Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023015828 Filed on March 01, 2023

Income Statement

Concept	2022 Q4	2022 Q1	2022
Revenue	$23.47M	$21.62M	$90.72M
YoY Change	13.18%	61.78%	28.34%
Cost Of Revenue	$7.443M	$6.180M	$27.33M
YoY Change	24.63%	61.27%	35.91%
Gross Profit	$16.03M	$15.44M	$63.39M
YoY Change	8.55%	61.98%	25.33%
Gross Profit Margin	68.29%	71.42%	69.88%
Selling, General & Admin	$7.668M	$8.510M	$33.55M
YoY Change	-9.81%	60.93%	9.04%
% of Gross Profit	47.84%	55.12%	52.93%
Research & Development	$16.46M	$14.13M	$58.21M
YoY Change	10.56%	35.86%	24.17%
% of Gross Profit	102.69%	91.5%	91.82%
Depreciation & Amortization	$361.0K	$320.0K	$1.377M
YoY Change	15.71%		25.3%
% of Gross Profit	2.25%	2.07%	2.17%
Operating Expenses	$24.13M	$22.64M	$91.76M
YoY Change	3.15%	44.31%	18.18%
Operating Profit	-$8.100M	-$7.197M	-$28.37M
YoY Change	-6.09%	16.95%	4.81%
Interest Expense	$819.0K	$2.489M	$828.0K
YoY Change	-0.12%	-1655.63%	-42.22%
% of Operating Profit
Other Income/Expense, Net			$309.0K
YoY Change			-161.31%
Pretax Income	-$7.281M	-$4.708M	-$27.23M
YoY Change	-6.71%	-25.52%	4.19%
Income Tax	$41.00K	$346.0K	$451.0K
% Of Pretax Income
Net Earnings	-$7.317M	-$5.050M	-$27.67M
YoY Change	-8.23%	-20.8%	4.27%
Net Earnings / Revenue	-31.17%	-23.36%	-30.5%
Basic Earnings Per Share			-$0.28
Diluted Earnings Per Share	-$0.07	-$51.98K	-$0.28
COMMON SHARES
Basic Shares Outstanding	98.88M shares		97.82M shares
Diluted Shares Outstanding			97.82M shares

Balance Sheet

Concept	2022 Q4	2022 Q1	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$148.4M	$165.5M	$148.4M
YoY Change	-14.9%	91856.67%	-14.9%
Cash & Equivalents	$20.02M	$44.99M	$20.02M
Short-Term Investments	$128.4M	$120.5M	$128.4M
Other Short-Term Assets	$4.793M	$7.737M	$4.793M
YoY Change	-41.94%	25690.0%	-41.94%
Inventory	$23.82M	$12.47M	$23.82M
Prepaid Expenses
Receivables	$11.51M	$10.21M	$11.51M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$188.5M	$195.9M	$188.5M
YoY Change	-5.29%	93203.81%	-5.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.790M	$7.520M	$6.614M
YoY Change	1.79%		141.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$4.900M
YoY Change		-95.74%
Other Assets	$535.0K	$724.0K	$535.0K
YoY Change	-35.39%		-35.39%
Total Long-Term Assets	$7.149M	$8.244M	$7.149M
YoY Change	100.31%	-92.83%	100.31%
TOTAL ASSETS
Total Short-Term Assets	$188.5M	$195.9M	$188.5M
Total Long-Term Assets	$7.149M	$8.244M	$7.149M
Total Assets	$195.7M	$204.2M	$195.7M
YoY Change	-3.43%	77.21%	-3.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.65M		$10.65M
YoY Change	137.06%		137.06%
Accrued Expenses	$8.017M		$13.62M
YoY Change	-28.2%		22.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.79M	$19.44M	$24.79M
YoY Change	57.9%	1384.12%	57.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.429M	$4.748M	$3.429M
YoY Change	-27.1%	-48.45%	-27.1%
Total Long-Term Liabilities	$3.429M	$4.748M	$3.429M
YoY Change	-27.1%	-48.45%	-27.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.79M	$19.44M	$24.79M
Total Long-Term Liabilities	$3.429M	$4.748M	$3.429M
Total Liabilities	$28.22M	$24.19M	$28.22M
YoY Change	38.3%	129.94%	38.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$157.7M
YoY Change	21.28%
Common Stock	$49.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$167.4M	$180.0M	$167.4M
YoY Change
Total Liabilities & Shareholders Equity	$195.7M	$204.2M	$195.7M
YoY Change	-3.43%	77.21%	-3.43%

Cashflow Statement

Concept	2022 Q4	2022 Q1	2022
OPERATING ACTIVITIES
Net Income	-$7.317M	-$5.050M	-$27.67M
YoY Change	-8.23%	-20.8%	4.27%
Depreciation, Depletion And Amortization	$361.0K	$320.0K	$1.377M
YoY Change	15.71%		25.3%
Cash From Operating Activities	-$5.831M	-$8.403M	-$22.10M
YoY Change	-48.76%	5151.88%	2.25%
INVESTING ACTIVITIES
Capital Expenditures	$317.0K	-$180.0K	$1.109M
YoY Change	-136.86%		-176.85%
Acquisitions
YoY Change
Other Investing Activities	-$6.130M	-$2.752M	-$10.62M
YoY Change	-94.06%		-87.16%
Cash From Investing Activities	-$6.447M	-$2.932M	-$11.73M
YoY Change	-93.8%		-86.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$54.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	289.0K	54.00K	$822.0K
YoY Change	-101.44%		-99.39%
NET CHANGE
Cash From Operating Activities	-5.831M	-8.403M	-$22.10M
Cash From Investing Activities	-6.447M	-2.932M	-$11.73M
Cash From Financing Activities	289.0K	54.00K	$822.0K
Net Change In Cash	-11.99M	-11.28M	-$36.77M
YoY Change	-91.15%	6950.63%	-223.97%
FREE CASH FLOW
Cash From Operating Activities	-$5.831M	-$8.403M	-$22.10M
Capital Expenditures	$317.0K	-$180.0K	$1.109M
Free Cash Flow	-$6.148M	-$8.223M	-$23.20M
YoY Change	-41.56%		15.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity File Number EntityFileNumber	001-40842
CY2022	dei	Entity Registrant Name EntityRegistrantName	Valens Semiconductor Ltd.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 Hanagar St. POB 7152
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Hod Hasharon
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	4501309
CY2022	dei	Entity Address Country EntityAddressCountry	IL
CY2022	dei	Security12b Title Security12bTitle	Ordinary shares, no par value
CY2022	dei	Trading Symbol TradingSymbol	VLN
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	98876266	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	412000	usd
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1006250	shares
CY2022Q4	vln	Forfeitures Shares Liability Noncurrent ForfeituresSharesLiabilityNoncurrent	1751000	usd
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Auditor Firm AuditorFirmId	1309
CY2022	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2022	dei	Auditor Name AuditorName	Kesselman & Kesselman
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20024000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56791000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	128363000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	117568000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11514000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7095000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4793000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8255000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	23816000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	9322000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	188510000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	199031000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2790000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2741000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3824000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	535000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	828000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7149000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3569000	usd
CY2022Q4	us-gaap	Assets Assets	195659000	usd
CY2021Q4	us-gaap	Assets Assets	202600000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	10651000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4493000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6206000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4583000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1811000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6121000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6623000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24789000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15699000	usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1006250	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1006250	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1006250	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1006250	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1006250	shares
CY2021Q4	vln	Forfeitures Shares Liability Noncurrent ForfeituresSharesLiabilityNoncurrent	4658000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1624000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	66266000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	54000	usd
CY2021Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	46000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3429000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4704000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	28218000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	20403000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	98876266	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	98876266	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	97122405	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	97122405	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	49000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	49000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	325067000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312156000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157675000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-130008000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167441000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	182197000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195659000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	202600000	usd
CY2022	us-gaap	Revenues Revenues	90715000	usd
CY2021	us-gaap	Revenues Revenues	70684000	usd
CY2020	us-gaap	Revenues Revenues	56910000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	27325000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	20105000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	13432000	usd
CY2022	us-gaap	Gross Profit GrossProfit	63390000	usd
CY2021	us-gaap	Gross Profit GrossProfit	50579000	usd
CY2020	us-gaap	Gross Profit GrossProfit	43478000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58207000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46875000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44725000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16959000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14214000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13657000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16593000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16556000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7884000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	91759000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	77645000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-28369000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-27066000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-22788000	usd
CY2022	vln	Change In Fair Value Of Forfeiture Share ChangeInFairValueOfForfeitureShare	2907000	usd
CY2021	vln	Change In Fair Value Of Forfeiture Share ChangeInFairValueOfForfeitureShare	-173000	usd
CY2022	vln	Financial Income Net FinancialIncomeNet	-1770000	usd
CY2021	vln	Financial Income Net FinancialIncomeNet	1102000	usd
CY2020	vln	Financial Income Net FinancialIncomeNet	3300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27232000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-26137000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19488000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	451000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	407000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	164000	usd
CY2022	vln	Income Loss From Continuing Operations After Income Taxes Minority Interest And Before Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsAfterIncomeTaxesMinorityInterestAndBeforeIncomeLossFromEquityMethodInvestments	27683000	usd
CY2021	vln	Income Loss From Continuing Operations After Income Taxes Minority Interest And Before Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsAfterIncomeTaxesMinorityInterestAndBeforeIncomeLossFromEquityMethodInvestments	26544000	usd
CY2020	vln	Income Loss From Continuing Operations After Income Taxes Minority Interest And Before Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsAfterIncomeTaxesMinorityInterestAndBeforeIncomeLossFromEquityMethodInvestments	19652000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	17000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27667000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26534000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-19635000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.25
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97820782	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33031205	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10448218	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-68323000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	406000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5329000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-19635000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-82223000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1246000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	9869000	usd
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	150179000	usd
CY2021	vln	Stock Issued During Period Value Merger Transaction Net StockIssuedDuringPeriodValueMergerTransactionNet	129660000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26534000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	182197000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	822000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	12089000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27667000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	167441000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27667000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-26534000	usd
CY2021	vln	Non Cash Interest Income NonCashInterestIncome	87000	usd
CY2020	vln	Non Cash Interest Income NonCashInterestIncome	524000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-19635000	usd
CY2022	us-gaap	Depreciation Depreciation	1377000	usd
CY2021	us-gaap	Depreciation Depreciation	1099000	usd
CY2020	us-gaap	Depreciation Depreciation	1093000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	12089000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9869000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	5329000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4259000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	496000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2821000	usd
CY2022	vln	Non Cash Interest Income NonCashInterestIncome	-1213000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	109000	usd
CY2022	vln	Change In Fair Value Of Forfeiture Shares ChangeInFairValueOfForfeitureShares	2907000	usd
CY2021	vln	Change In Fair Value Of Forfeiture Shares ChangeInFairValueOfForfeitureShares	-173000	usd
CY2022	vln	Reduction In The Carrying Amount Of Rou Assets ReductionInTheCarryingAmountOfROUAssets	1726000	usd
CY2021	vln	Equity Method Investment Earnings Net Of Dividend Received EquityMethodInvestmentEarningsNetOfDividendReceived	-18000	usd
CY2020	vln	Equity Method Investment Earnings Net Of Dividend Received EquityMethodInvestmentEarningsNetOfDividendReceived	-11000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4419000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1584000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	944000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-3462000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5286000	usd
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	741000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14494000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6163000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	449000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-293000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	411000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	5841000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2633000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1470000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1623000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	633000	usd
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1555000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-502000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1184000	usd
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	944000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1571000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	8000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22095000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21609000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19606000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	214522000	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	121947000	usd
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	86861000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	203902000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	39227000	usd
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	116036000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1109000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1443000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	861000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11729000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84163000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28314000	usd
CY2021	vln	Proceeds From Transactions Related To The Merger Net ProceedsFromTransactionsRelatedToTheMergerNet	134185000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	822000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1246000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	406000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	822000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	135431000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	406000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	-3765000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	816000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	1646000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36767000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	30475000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10760000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56791000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26316000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15556000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20024000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56791000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26316000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	214000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	417000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	139000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	317000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	44000	usd
CY2021	vln	Issuance Costs Incurred During Noncash Or Partial Noncash Transaction IssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	41000	usd
CY2022	vln	Operating Rightofuse Assets The Impact Recognized OperatingRightofuseAssetsTheImpactRecognized	4900	usd
CY2021	vln	Operating Rightofuse Assets The Impact Recognized OperatingRightofuseAssetsTheImpactRecognized	4900	usd
CY2020	vln	Operating Rightofuse Assets The Impact Recognized OperatingRightofuseAssetsTheImpactRecognized	4900	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	648000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	150179000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	4485000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>NOTE 1 - GENERAL:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.5in"><b>a.</b></td><td style="text-align: left">Valens Semiconductor Ltd. (hereafter “Valens”, and together with its wholly owned subsidiaries, the “Company”), was incorporated in Israel in 2006.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">Valens is a leading provider of semiconductor products (chips), operates in the audio-video and automotive industries, renowned for its Physical Layer (PHY) technologies, enabling resilient high-speed connectivity over simple, low-cost infrastructure. Valens is the inventor of the HDBaseT Technology, which enables the converged delivery of ultra-high-definition digital video and audio, Ethernet, control signals, USB and power through a single cable. In the audio-video space, Valens’ HDBaseT technology enables plug-and-play digital connectivity between ultra-HD video sources and remote displays. In the automotive domain, Valens’ product offering includes both symmetric and asymmetric connectivity solutions for high bandwidth transmission of native interfaces over a single low-cost wires and connectors. Valens’ advanced PHY technologies for the auto industry provides the safety and resilience required to handle the noisy automotive environment, addressing the needs of Advanced driver-assistance systems (ADAS), Automotive Data Solutions (ADS), infotainment, telematics and backbone connectivity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.5in"><b>b.</b></td><td style="text-align: left">As of December 31, 2022, and 2021, the Company has wholly owned subsidiaries in the United States, Japan, China, and Germany primarily for the marketing of and support for the Company’s products.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">In March 2010, the Company incorporated, together with Samsung Electronics, LG Electronics and Sony Pictures Technologies Inc., the HDBaseT Licensing LLC (the “LLC’) in Oregon, USA. The Company holds 25% of interest in the LLC. The LLC’s purposes are (i) to hold, obtain, license and/or acquire rights to certain intellectual property associated with or connected to or related to technical specifications developed by the HDBaseT Alliance, an Oregon nonprofit mutual benefit corporation (hereafter the “Alliance”), to enter into licensing arrangements for such intellectual property as required by the intellectual property rights policy of the Alliance; and (ii) to engage in any other lawful act or activity for which limited liability companies may be formed under the Act, and to do all things incidental to such purposes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.5in"><b>c.</b></td><td style="text-align: left">On September 29, 2021 (the “Closing Date”), the Company consummated a merger transaction (referred to as the “Merger Agreement Closing”) pursuant to a merger agreement, dated May 25, 2021 (the “Merger Agreement”), by and among the Company, PTK Acquisition Corp., a Delaware corporation whose common stock and warrants were then traded on the New York Stock Exchange (“PTK” or “SPAC”) and Valens Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”).</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">As a result of the Merger Agreement Closing, and upon consummation of other transactions contemplated by the Merger Agreement Closing (the “Transactions”), PTK became a wholly owned subsidiary of the Company, and (a) each of the PTK Warrants (total of 18,160,000 warrants (composed of 11,500,000 Public Warrants (“Public Warrants”) and 6,660,000 Private Warrants as both further disclosed in Note 9(b) below) convertible into 9,080,000 PTK common stock), automatically became a Company Warrant and all rights with respect to the PTK common stock underlying the PTK Warrants were automatically converted into rights with respect to Company Ordinary Shares and thereupon assumed by the Company, and (b) each PTK common stock issued and outstanding immediately prior to the Merger Agreement Closing was converted automatically into one Company Ordinary Share (for total of 5,867,763 Ordinary Shares including the Ordinary Shares subject to forfeiture). The total proceeds received by the Company as part of the above Transactions totaled to $29.9 million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; ">In connection therewith, the Company issued to the PTK’s sponsor: (a) 2,875,000 Ordinary Shares; and (b) 6,660,000 warrants, each of which entitles the holder thereof to purchase one half (1/2) of a Company Ordinary Share (the “Private Warrants”, refer also to Note 9(b) below) ((a) and (b) together, the “Sponsor Equity”). The Sponsor Equity is subject to certain terms and conditions, as set forth in the Merger Agreement. 35% of the Valens Ordinary Shares that the PTK sponsor received in respect of its PTK common stock (i.e., 1,006,250 Ordinary Shares), are subject to forfeiture if certain price targets for the Valens Ordinary Shares are not achieved within a certain period of time after the Closing Date or if an M&A Transaction (as defined in the Merger Agreement), does not occur at a certain minimum price (the “Forfeiture Shares”). Such Forfeiture Shares are classified as a liability and presented at fair value, although they are considered outstanding shares and are entitled to voting rights and distributions. Please refer in addition to Note 2(x).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">Concurrently with the execution of the Merger Agreement, Valens and certain accredited investors, entered into a series of subscription agreements, providing for the purchase by the PIPE (Private Investment in Public Equity) Investors at the Closing Date of an aggregate of 12,500,000 Valens Ordinary Shares at a price per share of $10.00, for gross proceeds to Valens of $125.0 million (collectively, the “PIPE Financing”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">Pursuant to the Merger Agreement Closing, and immediately prior to the consummation of the Merger and the PIPE Financing, the Company effected a recapitalization transaction whereby (i) all of the Company Preferred Shares were converted on a one-to-one basis into the Company Ordinary Shares, (ii) each Company Ordinary Share that was issued and outstanding immediately prior to the Closing Date, was reverse split into a number of the Company Ordinary Shares, such that each Company Ordinary Share had an implied value of $10.00 per share at the Closing Date, after giving effect to a stock reverse split ratio of 0.662531-to-one Ordinary Share (the “Reverse Stock Split”), ((i) and (ii) collectively the “Recapitalization”), (iii) the Company adopted amended and restated articles of association and (iv) any outstanding stock options of the Company issued and outstanding immediately prior to the Closing Date were adjusted to give effect to the foregoing transactions and remained outstanding and their exercise prices were adjusted accordingly. In addition, the Company eliminated the par value of its Ordinary Shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">As a result, all Ordinary Shares, options exercisable for Ordinary Shares, exercise prices and income (loss) per share amounts have been adjusted on a retroactive basis, for all periods presented in these consolidated financial statements, to reflect such Reverse Stock Split. The number of Preferred Shares has not been retrospectively adjusted in these consolidated financial statements since the conversion to Ordinary Shares occurred simultaneously with the Reverse Stock Split. The conversion of the Redeemable Convertible Preferred Shares was reflected on the Closing Date. The total number of Preferred Shares converted into Ordinary Shares on September 29, 2021, was 67,242,640 after giving effect of the Reverse Stock Split.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The net proceeds received by the Company as part of the Merger Agreement Closing and the PIPE Financing totaled to $131.6 million; underwriting fees and issuance costs (which consist of certain legal, accounting and other costs) amounted to $23.4 million, out of which an amount of $20.8 million was recorded as a reduction to Shareholders’ Equity, and an amount of $2.6 million was recorded within Statements of Operations ($2.1 million in the General and administrative expenses and $0.5 million was recorded in the Financial income, net).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">In addition, and as part of the Merger Agreement Closing and the PIPE Financing, i) the Company booked within the General and Administrative expenses an amount of approximately $3.4 million, due to options vesting acceleration resulted from the Merger Agreement Closing (refer also to note 11); and ii) the Company recorded the Forfeiture Shares liability of $4.5 million against the Additional Paid In Capital (refer also to note 2(x)).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.5in"><b>d.</b></td><td style="text-align: left">The breakout of the COVID-19 pandemic in 2020 and the global efforts to manage and control it, disrupted what was considered up until then the normal way of operating businesses, education systems, healthcare, and transportation among others. As a result of the pandemic, authorities around the world implemented unprecedented control measures. Those actions had a worldwide impact, including on the imbalance of the global supply chain, and adoption of hybrid work models. Our workforce and operations, and those of our customers, contract manufacturers, suppliers, and logistics providers, were affected as well.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The Company experienced some disruption to parts of our global semiconductor supply chain, including procuring necessary components and inputs, such as wafers and substrates, in a timely fashion, with suppliers increasing lead times or placing products on allocation. As a result of these supply chain disruptions, we increased customer order lead times. The pandemic resulted in authorities around the world implementing numerous unprecedented measures, such as travel restrictions quarantines, shelter-in-place order, and factory and office shutdowns, which impacted our workforce and operations and those of our customers, suppliers and logistics providers. Existing or new precautionary measures or modifications in our business practices and policies, may negatively impact our business or operations, especially if the spread of COVID-19 (including any variants) resumes. The degree to which the pandemic ultimately impacts our business and results of operations will depend on future developments beyond our control and to what extent normal economic and operating conditions resume.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">Currently, the macroeconomic environment is uncertain. The Company continues to experience various constraints in its supply chain and may continue to incur some challenges in obtaining certain essential components in a timely manner to meet demand. The Company monitors the implications of the pandemic and macroeconomic environment on its operations and may modify its business practices and policies from time to time. The ability to quantify the impact of the pandemic on the Company’s business remains limited and its effects on the business are unlikely to be fully realized, or reflected in the Company’s financial results, until future periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.5in"><b>e.</b></td><td style="text-align: left"><b>Military Tensions Between Russia and Ukraine</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">In February 2022, Russian forces launched a military invasion of Ukraine. In response, the United States, the European Union, United Kingdom and other governments have imposed significant economic sanctions on Russia, and Russia has responded with counter-sanctions. The war in Ukraine has disrupted international commerce and the global economy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">Although the Company does not currently operate in Ukraine or Russia and therefore does not experience any impact from the war in Ukraine, the duration and severity of the effects on its business and the global economy are inherently unpredictable. Management will continue to monitor the effects of the war in Ukraine and its potential further impacts on the Company.</p>
CY2022Q4	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	9080000	shares
CY2022	us-gaap	Debt Conversion Converted Instrument Type DebtConversionConvertedInstrumentType	one
CY2022	vln	Ordinary Shares Subject To Forfeiture OrdinarySharesSubjectToForfeiture	5867763	shares
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	29900000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6660000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2021Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	67242640	shares
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3400000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4500000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.5in"><b>b.</b></td><td style="text-align: left"><b>Use of estimates in preparation of financial statements</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet date, amounts of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates under different assumptions or circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.15pt; background-color: transparent"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "><span style="font-size: 10pt">On an ongoing basis, management evaluates its estimates, including those related to write-down for excess and obsolete inventories, the valuation of stock-based compensation awards</span>, <span style="font-size: 10pt">estimated useful lives of fixed assets and forfeiture shares liability. Such estimates often require the selection of appropriate valuation methodologies and models, and significant judgment in evaluating ranges of assumptions and financial inputs. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent"> </p>
CY2022Q4	vln	Short Term Deposits Interest Rate ShortTermDepositsInterestRate	0.042	pure
CY2021Q4	vln	Short Term Deposits Interest Rate ShortTermDepositsInterestRate	0.006	pure
CY2022	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	615000	usd
CY2021	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	790000	usd
CY2022	vln	Rate Of Monthly Salary Allocated Against Monthly Deposit RateOfMonthlySalaryAllocatedAgainstMonthlyDeposit	0.0833	pure
CY2022	vln	Description Of Severance Payment Valuation DescriptionOfSeverancePaymentValuation	Chinese subsidiary: The Chinese subsidiary liability for severance pay for its local employees is calculated in accordance with the Chinese law. The severance payment is calculated as the product of A x B, where A is the lower of a) most recent monthly salary paid to employees or b) cap of RMB 24,633 (approximately $3,600), and B is the length of employment in the Company (years). The Company does not make deposits in third party funds, hence, records the potential liability within Other long-term liabilities in the balance sheet.
CY2022	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width:0.5in"><b>m.</b></td><td style="text-align: left"><b>Revenue recognition</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The Company applies ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top; text-align: left"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: left">Identify the contract(s) with a customer;</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top; text-align: left"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: left">Identify the performance obligations in the contract;</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top; text-align: left"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: left">Determine the transaction price;</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top; text-align: left"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">(iv)</td><td style="text-align: left">Allocate the transaction price to the performance obligations in the contract;</td> </tr></table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top; text-align: left"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left">(v)</td><td style="text-align: left">Recognize revenue when (or as) the performance obligation is satisfied.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The Company uses the following practical expedients that are permitted under ASC 606:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top"> <td style="width: 1in"/><td style="width: 0.25in">●</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in sales and marketing expenses. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top"> <td style="width: 1in"/><td style="width: 0.25in">●</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">When a contract with a customer includes a material right to acquire future goods or services that are similar to the original goods or services in the contract and are provided in accordance with the terms of the original contract, the Company allocates the transaction price to the optional goods or services by reference to the goods or services expected to be provided and the corresponding expected consideration. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: left; text-indent: 0in; "> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; "><tr style="vertical-align: top"> <td style="width: 1in"/><td style="width: 0.25in">●</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">The Company applies the practical expedient of allowing it to disregard the effects of a financing component if the period between when the Company transfers the promised services to the customer and when the customer pays for the services will be one year or less.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The Company generates revenues mainly from selling semiconductor products (chips). Revenues are recognized when the customer (which includes distributors) obtains control over the Company’s product, typically upon shipment to the customer. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; ">The Company does not grant a right of return, refund, cancelation or termination. From time to time, the Company provides certain distributors with the right to free or discounted goods products in future periods that provides a material right to the customer. In such cases, such right is accounted for as a separate performance obligation. As of December 31, 2022, and 2021, the deferred revenues for such material rights were $0 thousand and $54 thousand, respectively. The amounts of revenues recognized in the period that were included in the opening deferred revenues balance were $54 and $76 thousand for the years ended December 31, 2022, and December 31, 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; "> </p>The Company generally provides to its customers a limited warranty assurance that the sold products are in compliance with the applicable specifications at the time of delivery. Under the Company’s standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items. To the extent the Company sells extended warranty, the recognition
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	54000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	54000	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	76000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	0	pure
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width:0.5in"><b>v.</b></td><td style="text-align: left"><b>Concentrations of credit risk</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent">Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, investments in short-term deposits and trade accounts receivable. As of December 31, 2022, and 2021, the Company had cash and cash equivalents totaling $20,024 thousand and $56,791 thousand, respectively, as well as short-term deposits of $128,363 thousand and $117,568 thousand as of December 31, 2022, and 2021, respectively, which are deposited in major Israeli, U.S, Japanese, German and Chinese financial institutions. The Company’s management believes that these financial institutions are financially sound.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in; background-color: transparent"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">The Company extends different levels of credit to customers and does not require collateral deposits. As of December 31, 2022, and 2021, the Company did not have allowances for doubtful accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"> </p>
CY2022Q4	vln	Number Of Market Service Provided NumberOfMarketServiceProvided	20024000	usd
CY2021Q4	vln	Number Of Market Service Provided NumberOfMarketServiceProvided	56791000	usd
CY2022	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	128363000	usd
CY2021	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	117568000	usd
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	4900000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9870000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4718000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13946000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4604000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	23816000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	9322000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	23000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	73000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9540000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8114000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6750000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5373000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2790000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2741000	usd
CY2022	us-gaap	Depreciation Depreciation	1377000	usd
CY2021	us-gaap	Depreciation Depreciation	1099000	usd
CY2020	us-gaap	Depreciation Depreciation	1093000	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	3203000	usd
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	3464000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	514000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	40000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	142000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	142000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2262000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2977000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6121000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6623000	usd
CY2021	vln	Lessee Operating Lease Liability Payments Due Next Twelve Month LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonth	1821000	usd
CY2021Q4	vln	Lessee Operating Lease Liability Payment Due Year Two LesseeOperatingLeaseLiabilityPaymentDueYearTwo	348000	usd
CY2021	vln	Lessee Operating Lease Liability Payment Due Year Three LesseeOperatingLeaseLiabilityPaymentDueYearThree	30000	usd
CY2021Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	2199000	usd
CY2021	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	2670000	usd
CY2020	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	2527000	usd
CY2022Q4	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P3Y
CY2022	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	31000	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	5500	sqm
CY2022Q4	us-gaap	Net Investment In Lease Threshold Period Past Due NetInvestmentInLeaseThresholdPeriodPastDue	P2Y
CY2022	vln	Extended Lease ExtendedLease	P1Y
CY2022	us-gaap	Payments For Rent PaymentsForRent	132000	usd
CY2022	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	1000	usd
CY2022Q4	vln	Share Price1 SharePrice1	7.4
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	2783000	usd
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	6563000	usd
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1006250	shares
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	2252000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2093000	usd
CY2022	us-gaap	Impairment Excluding Lessor Asset Under Operating Lease ImpairmentExcludingLessorAssetUnderOperatingLease	4900	usd
CY2022	vln	Operating Lease Liabilities Arising From Obtaining Operating Rightofuse Assets Excluding The Impac OperatingLeaseLiabilitiesArisingFromObtainingOperatingRightofuseAssetsExcludingTheImpac	648000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3824000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1811000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1624000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3435000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1309	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1949000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1855000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	134000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3938000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	503000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3435000	usd
CY2022	vln	Additional Royalties AdditionalRoyalties	0.1
CY2022Q4	vln	Total Value Of Open Purchase Orders TotalValueOfOpenPurchaseOrders	19418000	usd
CY2021Q4	vln	Total Value Of Open Purchase Orders TotalValueOfOpenPurchaseOrders	50591000	usd
CY2022Q4	vln	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1	5.37
CY2021Q4	vln	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1	7.7
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.01
CY2022Q4	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	18
CY2022Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	3330000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15449513	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.73
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	239610	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.28
CY2022	vln	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross	1635347	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.5
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	105627	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.86
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13948149	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.85
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11649042	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.77
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	407000	usd
CY2020	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	164000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	vln	Options Respectively Granted OptionsRespectivelyGranted	239610
CY2021	vln	Options Respectively Granted OptionsRespectivelyGranted	321777
CY2020	vln	Options Respectively Granted OptionsRespectivelyGranted	3347705
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	8116000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y10M20D
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6160000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9823000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5329000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4377000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1295000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2592000	usd
CY2021	vln	Issuance Costs Attributed To Forfeiture Shares IssuanceCostsAttributedToForfeitureShares	473000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	2298000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	311000	usd
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	849000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	109000	usd
CY2022	vln	Other Other	-309000	usd
CY2021	vln	Other Other	31000	usd
CY2020	vln	Other Other	32000	usd
CY2022	vln	Finance Income Net FinanceIncomeNet	-1770000	usd
CY2021	vln	Finance Income Net FinanceIncomeNet	1102000	usd
CY2020	vln	Finance Income Net FinanceIncomeNet	3300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-27667000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-26534000	usd
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19635000	usd
CY2022	vln	Net Income Loss Attributable To Common Stock Holders Basic And Diluted NetIncomeLossAttributableToCommonStockHoldersBasicAndDiluted	-27667000	usd
CY2021	vln	Net Income Loss Attributable To Common Stock Holders Basic And Diluted NetIncomeLossAttributableToCommonStockHoldersBasicAndDiluted	-37864000	usd
CY2020	vln	Net Income Loss Attributable To Common Stock Holders Basic And Diluted NetIncomeLossAttributableToCommonStockHoldersBasicAndDiluted	-33965000	usd
CY2022	vln	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	97820782	shares
CY2021	vln	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	33031205	shares
CY2020	vln	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	10448218	shares
CY2022	vln	Earnings Per Shares Basic EarningsPerSharesBasic	-0.28
CY2021	vln	Earnings Per Shares Basic EarningsPerSharesBasic	-1.15
CY2020	vln	Earnings Per Shares Basic EarningsPerSharesBasic	-3.25
CY2022	vln	Annual Rates AnnualRates	0.07	pure
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	407000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	164000	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	451000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0884	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27232000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-26137000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19488000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	360000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	306000	usd
CY2020	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	97000	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	91000	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	101000	usd
CY2020	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	67000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	451000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	407000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	164000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	360000	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	306000	usd
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	97000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	91000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	101000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	67000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	451000	usd
CY2022	vln	Proceeds From Transactions Related To The Merger Net ProceedsFromTransactionsRelatedToTheMergerNet		usd
CY2020	vln	Proceeds From Transactions Related To The Merger Net ProceedsFromTransactionsRelatedToTheMergerNet		usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27232000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-26137000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19488000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6263000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6011000	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4482000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5505000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3773000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3224000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	852000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2338000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1321000	usd
CY2022	vln	Effective Income Tax Rate Reconciliation Tax Prepayment Percent EffectiveIncomeTaxRateReconciliationTaxPrepaymentPercent	360000	usd
CY2021	vln	Effective Income Tax Rate Reconciliation Tax Prepayment Percent EffectiveIncomeTaxRateReconciliationTaxPrepaymentPercent	306000	usd
CY2020	vln	Effective Income Tax Rate Reconciliation Tax Prepayment Percent EffectiveIncomeTaxRateReconciliationTaxPrepaymentPercent	97000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	451000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	407000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	164000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17670000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21221000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	10861000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	7526000	usd
CY2022Q4	vln	Deferred Tax Assets Issuance Costs DeferredTaxAssetsIssuanceCosts	1009000	usd
CY2022Q4	vln	Employee And Payroll Accrued Expenses EmployeeAndPayrollAccruedExpenses	700000	usd
CY2021Q4	vln	Deferred Tax Assets Issuance Costs DeferredTaxAssetsIssuanceCosts	2338000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid		usd
CY2021Q4	vln	Employee And Payroll Accrued Expenses EmployeeAndPayrollAccruedExpenses	763000	usd
CY2022Q4	vln	Operating Lease Liabilities OperatingLeaseLiabilities	742000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1364000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	38000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	44000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	32384000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31892000	usd
CY2022Q4	vln	Operating Lease Rightofuse Assets OperatingLeaseRightofuseAssets	832000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	832000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	31552000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	31892000	usd
CY2022Q4	vln	Less Valuation Allowance For Deferred Tax Assets LessValuationAllowanceForDeferredTaxAssets	-31552000	usd
CY2021Q4	vln	Less Valuation Allowance For Deferred Tax Assets LessValuationAllowanceForDeferredTaxAssets	-31892000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31552000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31892000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	340000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9595000	usd
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4500000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.50	pure
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2022	vln	Revenue Revenue	90715000	usd
CY2020	vln	Revenue Revenue	70684000	usd
CY2019	vln	Revenue Revenue	56910000	usd
CY2022Q4	vln	Long Lived Assets LongLivedAssets	6614000	usd
CY2021Q4	vln	Long Lived Assets LongLivedAssets	2741000	usd
CY2022	vln	Issuance Costs Incurred During Noncash Or Partial Noncash Transaction IssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2020Q4	vln	Long Lived Assets LongLivedAssets	2353000	usd
CY2020	vln	Issuance Costs Incurred During Noncash Or Partial Noncash Transaction IssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	vln	Options Grants In Period OptionsGrantsInPeriod	239610	shares
CY2021	vln	Options Grants In Period OptionsGrantsInPeriod	321777	shares
CY2020	vln	Options Grants In Period OptionsGrantsInPeriod	3347705	shares
CY2022Q4	vln	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	6.28
CY2021Q4	vln	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	1.04
CY2020Q4	vln	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	0.86
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	515103	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	7398	shares
CY2022	vln	Fair Value FairValue	The fair value of the stock options that were granted during the year ended December 31, 2022, is $362 thousand, which is expected to be recognized over a 3-4-years vesting period, and the fair value of the RSUs is $2,603 thousand, which is expected to be recognized over a 1-4-years vesting period.
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	362000	usd
CY2022	vln	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue	2603000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	401000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	172000	usd
CY2020Q1	vln	Term Of Employment TermOfEmployment	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber	814272	shares
CY2021Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	3396000	usd
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	1545000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	142000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	142000	usd
CY2020	vln	Change In Fair Value Of Forfeiture Share ChangeInFairValueOfForfeitureShare		usd
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.25
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97820782	shares
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2020	vln	Change In Fair Value Of Forfeiture Shares ChangeInFairValueOfForfeitureShares		usd
CY2021	vln	Reduction In The Carrying Amount Of Rou Assets ReductionInTheCarryingAmountOfROUAssets		usd
CY2020	vln	Reduction In The Carrying Amount Of Rou Assets ReductionInTheCarryingAmountOfROUAssets		usd
CY2022	vln	Equity Method Investment Earnings Net Of Dividend Received EquityMethodInvestmentEarningsNetOfDividendReceived		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		usd
CY2020	us-gaap	Stock Issued1 StockIssued1		usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4485	usd
CY2020	vln	Issuance Costs Attributed To Forfeiture Shares IssuanceCostsAttributedToForfeitureShares		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2020	vln	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	10448218	shares
CY2021	vln	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	33031205	shares
CY2022	vln	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	97820782	shares
CY2022	vln	Earnings Per Shares Diluted EarningsPerSharesDiluted	-0.28
CY2021	vln	Earnings Per Shares Diluted EarningsPerSharesDiluted	-1.15
CY2020	vln	Earnings Per Shares Diluted EarningsPerSharesDiluted	-3.25
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2020	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001863006

Files In Submission

Name	View Source	Status
0001213900-23-015828-index-headers.html	Edgar Link	pending
0001213900-23-015828-index.html	Edgar Link	pending
0001213900-23-015828.txt	Edgar Link	pending
0001213900-23-015828-xbrl.zip	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
f20f2022ex12-1_valenssemi.htm	Edgar Link	pending
f20f2022ex12-2_valenssemi.htm	Edgar Link	pending
f20f2022ex13-1_valenssemi.htm	Edgar Link	pending
f20f2022ex13-2_valenssemi.htm	Edgar Link	pending
f20f2022ex15-1_valenssemi.htm	Edgar Link	pending
f20f2022ex8-1_valenssemi.htm	Edgar Link	pending
f20f2022_valenssemicond.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f20f2022_valenssemicond_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vln-20221231.xsd	Edgar Link	pending
vln-20221231_cal.xml	Edgar Link	unprocessable
vln-20221231_def.xml	Edgar Link	unprocessable
vln-20221231_lab.xml	Edgar Link	unprocessable
vln-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VLN
Valens Semiconductor Ltd. Stock $vln

2022 Q4 Form 20-F Financial Statement

#000121390023015828 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VLN Valens Semiconductor Ltd. Stock $vln

2022 Q4 Form 20-F Financial Statement

#000121390023015828 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VLN
Valens Semiconductor Ltd. Stock $vln